Based on the KANGJI MED.HLDS DL-00001 stock forecast from 0 analysts, the average analyst target price for KANGJI MED.HLDS DL-00001 is not available over the next 12 months. KANGJI MED.HLDS DL-00001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of KANGJI MED.HLDS DL-00001 is Bullish , which is based on 6 positive signals and 2 negative signals. At the last closing, KANGJI MED.HLDS DL-00001’s stock price was EUR 0.70. KANGJI MED.HLDS DL-00001’s stock price has changed by -0.71% over the past week, +2.96% over the past month and -14.72% over the last year.
No recent analyst target price found for KANGJI MED.HLDS DL-00001
No recent average analyst rating found for KANGJI MED.HLDS DL-00001
Company Overview KANGJI MED.HLDS DL-00001
Kangji Medical Holdings Limited, an investment holding company, engages in the design, development, manufacture, and sale of minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, such as trocars, uterine manipulator, specimen retrieval bag, incision dilator, powered linear stapler and reloads, endoscopic stapler, suction and irrigation sets, closure forceps, and visual guidance D and C suction probe, as well as polymer ligation clips. It provides disposable electrocoagulation forceps and ultrasonic scalpels soft tissue cutting and hemostatic scalpel, reusable ultrasonic scalpels soft tissue cutting and hemostatic scalpel, and laparoscopic surgical instrument. In addition, the company offers instruments, including 4K UHD fluorescence camera system, 4K-ultra resolution endovision camera system, uterin visual guidance surgical system, ultrasonic soft tissue cutting and hemostatic surgical system, cold light source, morcellator, and insufflator. Its products are used in various specialties, such as obstetrics and gynecology, urology, general surgery, and thoracic surgery. The company sells products to a network of distributors, hospitals, and other customers. The company was founded in 2004 and is headquartered in Hangzhou, China. Read Less
Kangji Medical Holdings Limited, an investment holding company, engages in the design, development, manufacture, and sale of minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, such as trocars, ...Read More
Frequently Asked Questions About KANGJI MED.HLDS DL-00001 (50J:F) Stock
Stock Target Advisor's fundamental analysis for KANGJI MED.HLDS DL-00001's stock is Bullish .
50J:F stock's dividend yield is 26.89%.
Our analysis grades 50J:F stock's dividend yield at A+. This means that 50J:F stock's dividend yield is above 100% of the stocks in the Medical Instruments & Supplies sector in the F exchange.
Based on this 50J:F may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 50J:F's stock to indicate what its average analyst target is.
50J:F stock's Price/Earning ratio is 11.08.
Our analysis grades 50J:F stock's Price / Earning ratio at A-. This means that 50J:F stock's Price/Earning ratio is above 7.999999999999996% of the stocks in the Medical Instruments & Supplies sector in the F exchange.
Based on this 50J:F may be undervalued for its sector.
The last closing price of 50J:F's stock was EUR 0.70.
The most recent market capitalization for 50J:F is EUR 0.87B.
Unfortunately we do not have enough analyst data on 50J:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains KANGJI MED.HLDS DL-00001's stock.
As per our most recent records KANGJI MED.HLDS DL-00001 has 964 Employees.
KANGJI MED.HLDS DL-00001's registered address is Tonglu Economic Development Zone, Hangzhou, China, 311501.
You can get more information about it from KANGJI MED.HLDS DL-00001's website at https://www.kangjimedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Frequently Asked Questions About KANGJI MED.HLDS DL-00001 (50J:F) Stock
Stock Target Advisor's fundamental analysis for KANGJI MED.HLDS DL-00001's stock is Bullish .
50J:F stock's dividend yield is 26.89%.
Our analysis grades 50J:F stock's dividend yield at A+. This means that 50J:F stock's dividend yield is above 100% of the stocks in the Medical Instruments & Supplies sector in the F exchange.
Based on this 50J:F may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 50J:F's stock to indicate what its average analyst target is.
50J:F stock's Price/Earning ratio is 11.08.
Our analysis grades 50J:F stock's Price / Earning ratio at A-. This means that 50J:F stock's Price/Earning ratio is above 7.999999999999996% of the stocks in the Medical Instruments & Supplies sector in the F exchange.
Based on this 50J:F may be undervalued for its sector.
The last closing price of 50J:F's stock was EUR 0.70.
The most recent market capitalization for 50J:F is EUR 0.87B.
Unfortunately we do not have enough analyst data on 50J:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains KANGJI MED.HLDS DL-00001's stock.
As per our most recent records KANGJI MED.HLDS DL-00001 has 964 Employees.
KANGJI MED.HLDS DL-00001's registered address is Tonglu Economic Development Zone, Hangzhou, China, 311501.
You can get more information about it from KANGJI MED.HLDS DL-00001's website at https://www.kangjimedical.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 50J:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
